February 23, 2009 - Alsius Corp. said today it has signed an agreement with a subsidiary of ZOLL Medical Corp. under which Alsius will sell to ZOLL substantially all the assets constituting Alsius’ intravascular temperature management device business for a purchase price of $12 million in cash.

February 23, 2009 - Daiichi Sankyo Co. Ltd and Eli Lilly and Co. announced today that the European Commission granted marketing authorization for EFFIENT (prasugrel) for the prevention of atherothrombotic events in patients with acute coronary syndrome (ACS) undergoing PCI.

February 20, 2009 - The Academy of Molecular Imaging recommends that PET imaging facilities closely monitor NOPR communications and be prepared for coverage changes on the date the final coverage decision is issued.

February 20, 2009 - MiCardia Corp. this week announced the worlds’ first dynamic adjustment of the mitral valve annular geometry on a beating heart.

February 20, 2009 – The Heart Failure Society of America (HFSA) recently posted 11 fact-filled education modules on its Web site (www.abouthf.org) where doctors can send their patients for more information to help them maintain their cardiovascular health.

February 19, 2009 - When it comes to a heart attack, every second counts, and the Occluded Artery Trial (OAT) underscores how very important it is for individuals experiencing a heart attack to take their symptoms seriously, call 911, and undergo prompt treatment, says the Society for Cardiovascular Angiography and Interventions (SCAI).

February 19, 2009 - C. R. Bard Inc. this week said it received pre-market approval (PMA) from the FDA to market the LifeStent FlexStar and FlexStar XL Vascular Stent Systems, which are approved for the treatment of occlusive disease in native superficial femoral arteries (SFA) and proximal popliteal arteries.

February 19, 2009 - The New England Journal of Medicine this week published the results from the SYNTAX trial, in which percutaneous coronary intervention (PCI) using the TAXUS Express2 Paclitaxel-Eluting Coronary Stent was compared to contemporary coronary artery bypass graft (CABG) surgery in patients with the most complex coronary artery disease (CAD).

February 19, 2009 - Acusphere Inc. today submitted an amendment to its new drug application (NDA) for its ultrasound contrast agent Imagify (perflubutane polymer microspheres for injectable suspension), which is designed for the detection of coronary artery disease.

February 19, 2009 – Siemens Healthcare released the Symbia E single detector imaging system to its Symbia family of scanners. The Symbia E is designed to be a a high-quality, cost-effective single photon emission computed tomography (SPECT) system that can help improve clinical confidence, reliability and versatility.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now